Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jun;14(6):419-29.
doi: 10.1038/nrc3725. Epub 2014 May 15.

Connections of Nicotine to Cancer

Affiliations
Review

Connections of Nicotine to Cancer

Sergei A Grando. Nat Rev Cancer. .

Abstract

This Opinion article discusses emerging evidence of direct contributions of nicotine to cancer onset and growth. The list of cancers reportedly connected to nicotine is expanding and presently includes small-cell and non-small-cell lung carcinomas, as well as head and neck, gastric, pancreatic, gallbladder, liver, colon, breast, cervical, urinary bladder and kidney cancers. The mutagenic and tumour-promoting activities of nicotine may result from its ability to damage the genome, disrupt cellular metabolic processes, and facilitate growth and spreading of transformed cells. The nicotinic acetylcholine receptors (nAChRs), which are activated by nicotine, can activate several signalling pathways that can have tumorigenic effects, and these receptors might be able to be targeted for cancer therapy or prevention. There is also growing evidence that the unique genetic makeup of an individual, such as polymorphisms in genes encoding nAChR subunits, might influence the susceptibility of that individual to the pathobiological effects of nicotine. The emerging knowledge about the carcinogenic mechanisms of nicotine action should be considered during the evaluation of regulations on nicotine product manufacturing, distribution and marketing.

Similar articles

See all similar articles

Cited by 88 articles

See all "Cited by" articles

References

    1. Exp Cell Res. 2007 Oct 1;313(16):3542-55 - PubMed
    1. J Biol Chem. 2005 Nov 25;280(47):39220-8 - PubMed
    1. Cancer Res. 1999 Feb 1;59(3):590-6 - PubMed
    1. PLoS One. 2013 Jun 18;8(6):e67252 - PubMed
    1. Mol Cancer Res. 2014 Jan;12(1):14-23 - PubMed

Publication types

LinkOut - more resources

Feedback